View Press Releases
-
ORNL Team Enlists World’s Fastest Supercomputer to Combat the Coronavirus
OAK RIDGE, TN - Mar 5, 2020 - Researchers at the US Department of Energys (DOEs) Oak Ridge National Laboratory (ORNL) have used the worlds most powerful and smartest supercomputer, the IBM AC922 Summit, to identify 77 small-molecule drug compounds that might warrant further study in the fight against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease outbreak
Mar 5, 2020
-
BOC Sciences Supplies Four Top Class Active Pharmaceutical Ingredients (APIs): Daunorubicin, Doxorubicin, Epirubicin and Valrubicin for Cancer Treatment
LONG ISLAND CITY, NY, UNITED STATES - Mar 5, 2020 - The world's leading chemical vendor BOC Sciences started to supply top class active pharmaceutical ingredients (APIs) and excipients for drug formulation purposes years ago, aiming to provide an integrated, one-stop solution for large pharmaceutical companies that has outsourcing needs
Mar 4, 2020
-
Beijing University of Chinese Medicine collaborates with Elsevier to launch first branch of traditional Chinese medicine taxonomy
NEW YORK, NY, UNITED STATES - Mar 4, 2020 - Elsevier, a global leader in information analytics, specializing in science and health, launched the first branch of its Traditional Chinese Medicine (TCM) taxonomy in collaboration with Beijing University of Chinese Medicine (BUCM), a leader in the field of TCM research and medical treatment
Mar 4, 2020
-
Signant Health Appoints Ian Jennings as Chief Commercial Officer
PHILADELPHIA, PA - Mar 4, 2020 - Ian brings 30 years of commercial technology experience in the life sciences industry, with a proven track record of developing and leading successful sales and marketing teams in clinical and healthcare innovation
Mar 4, 2020
-
New Multiplex mode for ZEISS Airyscan 2 enables fast and gentle confocal microscopy
JENA, GERMANY - Mar 3, 2020 - The new Multiplex mode for ZEISS Airyscan 2 delivers more information in less time. Smart illumination and detection schemes allow parallel pixel acquisition for fast and gentle confocal microscopy
Mar 3, 2020
-
MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020
GUILDFORD, UNITED KINGDOM - Mar 3, 2020 - MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the imaging science community at the 15th European Molecular Imaging Meeting (EMIM 2020) on March 24 – 27, 2020 in Thessaloniki, Greece
Mar 3, 2020
-
WCG CenterWatch iConnect Selected as Patient Recruitment Management System for The Michael J. Fox Foundation’s Clinical Study Matching Tool, Fox Trial Finder
PRINCETON, NJ - Mar 3, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael J
Mar 3, 2020
-
BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations
WESTBURY, NY - Mar 3, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, announced that it is now providing same-day delivery of fresh blood, LEUKOMAX® leukopaks and buffy coats from normal and disease-state donors to cell and gene therapy researchers in the UK
Mar 3, 2020
-
COVID-19 could be identified in minutes via mobile technology
AUCKLAND, NEW ZEALAND - Mar 3, 2020 - Fast testing during viral outbreaks, such as the current COVID-19, could assist to prevent its spread, saving lives and money
Mar 2, 2020
-
Olaris Announces Findings from Exploratory Analysis of Biomarkers that Predict Patient Responsiveness to Trastuzumab Therapy
WALTHAM, MA, UNITED STATES - Mar 2, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced the findings from its exploratory analysis of biomarkers of response (BoR) that predict whether a HER2-positive (Her2+) metastatic breast cancer patient will respond to Herceptin® (trastuzumab) therapy
Mar 2, 2020
-
Solentim names Mark Truesdale as new CEO
BOURNEMOUTH, UK - Mar 2, 2020 - Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEO
Mar 1, 2020
-
Legit™ Unveils A New Collaboration Software For Life Sciences
CAMBRIDGE, MA, UNITED STATES - Feb 28, 2020 - Legit, the leading life sciences collaboration platform, announced today the launch of their new collaboration software geared towards the life sciences
Feb 28, 2020
-
Alfa Chemistry Introduced Functionalized Nanomaterials
NEW YORK, NY - Feb 28, 2020 - On February 20, 2020, Alfa Chemistry announced to introduce a wide range of functionalized nanomaterials to meet the increasing demand from their global customers
Feb 27, 2020
-
Menarini Silicon Biosystems To Announce New Solutions for Advancing Liquid Biopsy in Clinical Research
BOLOGNA, ITALY AND HUNTINGDON VALLEY, PA - Feb 27, 2020 - Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysis
Feb 27, 2020
-
Bio Filters For Air Pollution Control Outlook, Product, Industry Developments and Opportunities
ALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market report
Feb 26, 2020
-
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China
SAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutations
Feb 25, 2020
-
Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Banks intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roches PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors
Feb 25, 2020
-
The Pistoia Alliance’s UDM Project Reaches Major Milestone
BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)
Feb 25, 2020
-
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.
PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc
Feb 25, 2020
-
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies
Feb 24, 2020